Skip to main content
Clinical Trials/CTRI/2017/11/010418
CTRI/2017/11/010418
Completed
Phase 4

Comparative assessment of the efficacy, safety and cost effectiveness of sertaconazole (2%) cream versus luliconazole (1%) cream in patients with dermatophytoses : A prospective, Randomized , open label, parallel study - CAESCESVLPDPROLPS

Government Medical College0 sites59 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- DERMATOPHYTOSES PATIENTSHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
Sponsor
Government Medical College
Enrollment
59
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 31, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Adults between the age group of 18 to 70 years of either gender, with clinical diagnosis and mycological confirmation (positive KOH test) for tinea corporis and tinea cruris infections, will be included in the study.
  • 2\)Patient having a Physician global assessment (PGA) composite score of at least 5 will be included in the study.
  • 3\)Patient willing to give written informed consent will be included in the study

Exclusion Criteria

  • 1\)Patients having clinical diagnosis of tinea infections other than tinea corporis and tinea cruris,
  • 2\)Patients having extensive fungal infection,
  • 3\)Patients who had received topical or oral antifungal agents upto four weeks prior to the initiation of the study,
  • 4\)History of hypersensitivity to study drugs,
  • 5\)Immunocompromised patients,
  • 6\)Patients having superadded bacterial infection,
  • 7\)Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials